| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adequacy of CT-guided biopsies with histomolecular subtyping of pulmonary adenocarcinomas: Influence of ATS/ERS/IASLC guidelines
|
Ferretti, Gilbert R.
|
|
2013
|
82 |
1 |
p. 69-75
7 p.
|
artikel
|
| 2 |
A genome-wide association study for malignant mesothelioma risk
|
Cadby, Gemma
|
|
2013
|
82 |
1 |
p. 1-8
8 p.
|
artikel
|
| 3 |
An evaluation of the possible interaction of gastric acid suppressing medication and the EGFR tyrosine kinase inhibitor erlotinib
|
Hilton, J.F.
|
|
2013
|
82 |
1 |
p. 136-142
7 p.
|
artikel
|
| 4 |
A prospective, phase II, open-label study (JO22903) of first-line erlotinib in Japanese patients with epidermal growth factor receptor (EGFR) mutation-positive advanced non-small-cell lung cancer (NSCLC)
|
Goto, Koichi
|
|
2013
|
82 |
1 |
p. 109-114
6 p.
|
artikel
|
| 5 |
Cisplatin chemotherapy induces odor perception changes in bronchial cancer patients
|
Joussain, P.
|
|
2013
|
82 |
1 |
p. 168-170
3 p.
|
artikel
|
| 6 |
Contents
|
|
|
2013
|
82 |
1 |
p. vii-ix
nvt p.
|
artikel
|
| 7 |
Cost effectiveness of first-line pemetrexed plus platinum compared with other regimens in the treatment of patients with nonsquamous non-small cell lung cancer in the US outpatient setting
|
Shah, Manan
|
|
2013
|
82 |
1 |
p. 121-127
7 p.
|
artikel
|
| 8 |
Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: Results from IALT, JBR.10 and ANITA
|
Graziano, Stephen L.
|
|
2013
|
82 |
1 |
p. 149-155
7 p.
|
artikel
|
| 9 |
Diagnostic method for the detection of KIF5B-RET transformation in lung adenocarcinoma
|
Go, Heounjeong
|
|
2013
|
82 |
1 |
p. 44-50
7 p.
|
artikel
|
| 10 |
Does age influence the symptom experience of lung cancer patients prior to surgery?
|
Oksholm, Trine
|
|
2013
|
82 |
1 |
p. 156-161
6 p.
|
artikel
|
| 11 |
Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial)
|
Reaume, M. Neil
|
|
2013
|
82 |
1 |
p. 115-120
6 p.
|
artikel
|
| 12 |
Editorial Board
|
|
|
2013
|
82 |
1 |
p. v-
1 p.
|
artikel
|
| 13 |
EGFR mutation analysis in sputum of lung cancer patients: A multitechnique study
|
Hubers, A. Jasmijn
|
|
2013
|
82 |
1 |
p. 38-43
6 p.
|
artikel
|
| 14 |
High expression of SNIP1 correlates with poor prognosis in Non-small cell lung cancer and SNIP1 interferes with the recruitment of HDAC1 to RB in vitro
|
Jeon, Hyo-Sung
|
|
2013
|
82 |
1 |
p. 24-30
7 p.
|
artikel
|
| 15 |
Inter-observer reproducibility of semi-automatic tumor diameter measurement and volumetric analysis in patients with lung cancer
|
Dinkel, J.
|
|
2013
|
82 |
1 |
p. 76-82
7 p.
|
artikel
|
| 16 |
NSE level in combined neuroendocrine and adenocarcinoma EGFR mutated lung cancer resistant to EGFR-TKI
|
Facchinetti, Francesco
|
|
2013
|
82 |
1 |
p. 177-178
2 p.
|
artikel
|
| 17 |
Outcomes following surgical treatment compared to radiation for stage I NSCLC: A SEER database analysis
|
Monirul Islam, K.M.
|
|
2013
|
82 |
1 |
p. 90-94
5 p.
|
artikel
|
| 18 |
Persistent unilateral facial pain in lung cancer patients with mediastinal nodal involvement
|
Pembroke, Catherine A.
|
|
2013
|
82 |
1 |
p. 173-175
3 p.
|
artikel
|
| 19 |
Phase II study of oral S-1 plus cisplatin with bevacizumab for advanced non-squamous non-small cell lung cancer
|
Kaira, Kyoichi
|
|
2013
|
82 |
1 |
p. 103-108
6 p.
|
artikel
|
| 20 |
Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): Patient outcomes and prognostic factors
|
Griffioen, Gwendolyn H.M.J.
|
|
2013
|
82 |
1 |
p. 95-102
8 p.
|
artikel
|
| 21 |
Radiochemotherapy as the standard treatment for both elderly and non-elderly fit patients with locally advanced (stage III) nonsmall cell lung cancer
|
Jeremic, Branislav
|
|
2013
|
82 |
1 |
p. 176-
1 p.
|
artikel
|
| 22 |
Regulation of SIRT2 levels for human non-small cell lung cancer therapy
|
Li, Ziming
|
|
2013
|
82 |
1 |
p. 9-15
7 p.
|
artikel
|
| 23 |
Response of CAIX and CAXII to in vitro re-oxygenation and clinical significance of the combined expression in NSCLC patients
|
Ilie, Marius
|
|
2013
|
82 |
1 |
p. 16-23
8 p.
|
artikel
|
| 24 |
Response to dasatinib in a patient with SQCC of the lung harboring a discoid-receptor-2 and synchronous chronic myelogenous leukemia
|
Pitini, Vincenzo
|
|
2013
|
82 |
1 |
p. 171-172
2 p.
|
artikel
|
| 25 |
Smoking status and self-reported race affect the frequency of clinically relevant oncogenic alterations in non-small-cell lung cancers at a United States-based academic medical practice
|
Yamaguchi, Norihiro
|
|
2013
|
82 |
1 |
p. 31-37
7 p.
|
artikel
|
| 26 |
Spatial and temporal distributions of lung cancer histopathology in the state of Maine
|
Hosgood III, H. Dean
|
|
2013
|
82 |
1 |
p. 55-62
8 p.
|
artikel
|
| 27 |
Support service use and interest in support services among lung cancer patients
|
Mosher, Catherine E.
|
|
2013
|
82 |
1 |
p. 162-167
6 p.
|
artikel
|
| 28 |
The clinicopathological significance of Lgr5 expression in lung adenocarcinoma
|
Ryuge, Shinichiro
|
|
2013
|
82 |
1 |
p. 143-148
6 p.
|
artikel
|
| 29 |
Up-regulation of pro-angiogenic factors and establishment of tolerance in malignant pleural effusions
|
Lieser, Elizabeth Ann T.
|
|
2013
|
82 |
1 |
p. 63-68
6 p.
|
artikel
|
| 30 |
Usefulness of immunohistochemistry for the detection of the BRAF V600E mutation in Japanese lung adenocarcinoma
|
Sasaki, Hidefumi
|
|
2013
|
82 |
1 |
p. 51-54
4 p.
|
artikel
|
| 31 |
What constitutes best supportive care in the treatment of advanced non-small cell lung cancer patients?—Results from the lung cancer economics and outcomes research (LUCEOR) study
|
Lester, J.F.
|
|
2013
|
82 |
1 |
p. 128-135
8 p.
|
artikel
|
| 32 |
10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45Gy (1.5Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)—A multicenter phase-II trial (CISTAXOL)
|
Eberhardt, Wilfried Ernst Erich
|
|
2013
|
82 |
1 |
p. 83-89
7 p.
|
artikel
|
Tijdschrift beschrijving